Accueil600812 • SHA
add
North China Pharmaceutical Group Corp
Dernière clôture
5,56 ¥
Variation sur la journée
5,53 ¥ - 5,60 ¥
Plage sur l'année
3,83 ¥ - 6,66 ¥
Volume moyen
18,86 M
Ratio cours/bénéfices
119,92
Rendement (dividendes)
0,18 %
Place boursière principale
SHA
Actualités des marchés
Données financières
Compte de résultat
Chiffre d'affaires
Résultat net
| (CNY) | sept. 2024info | Variation Y/Y |
|---|---|---|
Chiffre d'affaires | 2,33 Md | -15,04 % |
Charges d'exploitation | 539,22 M | -19,20 % |
Résultat net | 30,48 M | 2 035,14 % |
Marge bénéficiaire nette | 1,31 | 2 520,00 % |
Bénéfice par action | — | — |
EBITDA | 362,65 M | 6,65 % |
Taux d'imposition effectif | 32,92 % | — |
Bilan
Total des actifs
Total du passif
| (CNY) | sept. 2024info | Variation Y/Y |
|---|---|---|
Trésorerie/Invest. court terme | 1,72 Md | 15,99 % |
Total des actifs | 21,71 Md | 0,92 % |
Total du passif | 15,10 Md | -0,95 % |
Total des capitaux propres | 6,61 Md | — |
Actions en circulation | 1,72 Md | — |
Ratio cours/valeur comptable | 1,78 | — |
Rentabilité des actifs | 2,06 % | — |
Retour sur capitaux | 2,47 % | — |
Flux de trésorerie
Variation nette en trésorerie
| (CNY) | sept. 2024info | Variation Y/Y |
|---|---|---|
Résultat net | 30,48 M | 2 035,14 % |
Trésorerie (opérations) | 175,21 M | -46,70 % |
Trésorerie (invest.) | -153,19 M | 10,80 % |
Trésorerie (financement) | -76,80 M | 67,74 % |
Variation nette en trésorerie | -55,38 M | 30,27 % |
Flux de trésorerie dispo. | -660,87 M | -459,21 % |
À propos
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
Date de fondation
20 déc. 1992
Employés
10 159
